Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.64 |
| ▸ | CA1 | P00915 | 3/20 | 0.64 |
| ▸ | CA2 | P00918 | 3/20 | 0.64 |
| ▸ | CA9 | Q16790 | 2/20 | 0.64 |
| ▸ | CA4 | P22748 | 1/20 | 0.64 |
| ▸ | CA6 | P23280 | 1/20 | 0.64 |
| ▸ | CA5A | P35218 | 1/20 | 0.64 |
| ▸ | CA7 | P43166 | 1/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.50 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL839104 | 0.98 | CA12 (0.61) | CA12CA1CA2CA9CA4 | |
| Hydrochloric Acid SCHEMBL8856800 | 0.81 | CA12 (0.44) | CA12CA1CA2CA9CA4 | |
| SCHEMBL25667539 | 0.80 | ENPP2 (0.54) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL4640918 | 0.80 | ALDH1A1 (0.79) | CA12CA1CA2CA9CA4 | |
| SCHEMBL2376239 | 0.79 | ENPP2 (0.72) | ENPP2PTGS2 | |
| Hydrochloric Acid SCHEMBL5142727 | 0.78 | ALDH1A1 (0.76) | CA12CA1CA2CA9CA4 | |
| SCHEMBL1144444 | 0.78 | CA2 (1.00) | CA12CA1CA2CA9CA4 | |
| SCHEMBL2017578 | 0.78 | CA12 (0.64) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL5339648 | 0.77 | CA1 (0.59) | CA12CA1CA2CA9CA4 | |
| SCHEMBL5893440 | 0.77 | CA12 (0.59) | CA12CA1CA2CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110714208-B | Method for preparing 6- (sulfonyl methyl) phenanthridine compound through electrocatalysis | 常州工学院 | 2020-12-29 | — | — | CN | claimed |
| CN-110714208-A | Method for preparing 6- (sulfonyl methyl) phenanthridine compound through electrocatalysis | 常州工学院 | 2020-01-21 | — | — | CN | claimed |
| US-5109036-A | With alkysulfonylphenylhydrazine accelerator; storage stability | CECA, S.A. (FR) | 1992-04-28 | — | — | US | claimed |
| EP-0443916-A1 | Anaerobically curing adhesive compositions | CECA S.A. (FR) | 1991-08-28 | — | — | EP | claimed |
| JP-6234956-A | — | — | None | — | — | JP | disclosed |
| EP-4603480-A1 | INDOLE PHTHALOCYANINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN TUMOR DIAGNOSIS IMAGING | Jiangsu Yahong Meditech Co., Ltd. (CN) | 2025-08-20 | — | — | EP | disclosed |
| EP-4596537-A1 | NOVEL FLUORENE DERIVATIVE COMPOUND AND USE THEREOF | JD Bioscience Inc. (KR) | 2025-08-06 | — | — | EP | disclosed |
| US-20250186433-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | EPIVARIO, INC. | 2025-06-12 | — | — | US | disclosed |
| CN-119768391-A | Indole phthalocyanine compound, preparation method thereof and application thereof in tumor diagnostic imaging | 江苏亚虹医药科技股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| WO-2025022871-A1 | ANAEROBIC ADHESIVE, CURED PRODUCT, BONDED STACK, AND MOTOR | ソマール株式会社 | 2025-01-30 | — | — | WO | disclosed |
| US-12133852-B2 | ACSS2 inhibitors and methods of use thereof | EPIVARIO, INC. (US) | 2024-11-05 | — | — | US | disclosed |
| WO-2024078579-A1 | INDOLE PHTHALOCYANINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN TUMOR DIAGNOSIS IMAGING | 江苏亚虹医药科技股份有限公司 | 2024-04-18 | — | — | WO | disclosed |
| US-4298676-A | PH-SENSITIVE HYDRAZONE COMPOUNDS, ANTIFOGGING AGENTS | POLAROID CORPORATION (US) | 1981-11-03 | — | — | US | disclosed |
| US-4269925-A | PH-SENSITIVE ANTIFOGGING AGENTS HAVING AN ADDITION POLYMER BACKBONE WITH PENDANT ELECTRONEGATIVELY-SUBSTITUTED HYDROCARBYL HYDRAZINE GROUPS; PHOTO SELF-DEVELOPMENT FILMS | POLAROID CORPORATION (US) | 1981-05-26 | — | — | US | disclosed |
| US-4268592-A | PYRAZOLONE MAGENTA COUPLER | CIBA-GEIGY AG (CH) | 1981-05-19 | — | — | US | disclosed |
| US-4257952-A | PSYCHOTROPIC DRUGS, ANALGESICS, ANTIHISTAMINES | STERLING DRUG INC. (US) | 1981-03-24 | — | — | US | disclosed |
| US-4172834-A | ANALGESICS, ANTIHISTAMINES AND PSYCHOTROPIC AGENTS | STERLING DRUG INC. (US) | 1979-10-30 | — | — | US | disclosed |
| US-4151210-A | Process for the production of phenylalkyl sulphones | CIBA-GEIGY CORPORATION (US) | 1979-04-24 | — | — | US | disclosed |
| US-4062864-A | ANALGESIC, PSYCHOTROPIC, ANTIHISTAMINE | STERLING DRUG INC. (US) | 1977-12-13 | — | — | US | disclosed |
| US-3959309-A | ANALGESICS, PSYCHOTROPIC, ANTIHISTAMINE | STERLING DRUG INC. (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186433-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | ACSS2, GLS2, ADSS2 | CA12 466/4885CA1 634/4885CA2 1483/4885 |
| US-12133852-B2 | ACSS2 inhibitors and methods of use thereof | ACSS2, GLS2, ADSS2 | CA12 466/4885CA1 634/4885CA2 1483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.